The NGFA supports agricultural biotechnology and other scientific advancements that promote safe and abundant food and feed supply. However, the NGFA believes biotech-enhanced traits should be commercialized only after achieving broad, deep consumer acceptance, as well as authorizations from U.S. export markets, to enable the industry to meet customer preferences and maintain access to global markets. The NGFA advocates prudent policies to guard against the presence of unauthorized or restricted-use biotech-enhanced traits in the general commodity stream. It also advocates a responsible and commercially achievable tolerance for low-level presence in commodity shipments of biotech-enhanced traits that have been approved by the governmental authority in the exporting country.
Two NGFA economic analyses estimates that up to $2.9 billion in economic losses have been sustained by the U.S. corn, distillers grains and soy sectors in the aftermath of the enforcement of a zero-tolerance policy on Syngenta’s Agrisure Viptera™ MIR 162 corn technology in U.S. export shipments to China, where the trait has not been approved yet for import as food or feed. More information
Recent articles, press releases and issue advisories on ag biotechnology.